Compounds > torcetrapib
Page last updated: 2024-09-04

torcetrapib and Hyperaldosteronism

torcetrapib has been researched along with Hyperaldosteronism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hegele, RA; Joy, TR1
Funder, JW1
Burnier, M; Vogt, B1

Reviews

1 review(s) available for torcetrapib and Hyperaldosteronism

ArticleYear
Aldosterone and cardiovascular risk.
    Current hypertension reports, 2009, Volume: 11, Issue:6

    Topics: Aldosterone; Antihypertensive Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Humans; Hyperaldosteronism; Kidney Diseases; Metabolic Syndrome; Obesity; Quinolines

2009

Other Studies

2 other study(ies) available for torcetrapib and Hyperaldosteronism

ArticleYear
The failure of torcetrapib: what have we learned?
    British journal of pharmacology, 2008, Volume: 154, Issue:7

    Topics: Aldosterone; Anticholesteremic Agents; Blood Pressure; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Humans; Hyperaldosteronism; Oxazolidinones; Quinolines

2008
The off-target effects of torcetrapib.
    Endocrinology, 2009, Volume: 150, Issue:5

    Topics: Anticholesteremic Agents; Blood Pressure; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Drug Delivery Systems; Gene Expression Regulation; Humans; Hyperaldosteronism; Quinolines; Water-Electrolyte Imbalance

2009